Terms: = Prostate cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA AND Staging
4 results:
1. Optimization of prostate cancer patient lymph node staging via the integration of neutrophil-lymphocyte ratios, platelet-lymphocyte ratios, and
Wang Y; Tang Y; Gao X; Gan Y; Hu S; Chen MF; Cai Y
Prostate; 2022 Nov; 82(15):1415-1421. PubMed ID: 35860907
[TBL] [Abstract] [Full Text] [Related]
2. Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.
Dhondt B; De Bleser E; Claeys T; Buelens S; Lumen N; Vandesompele J; Beckers A; Fonteyne V; Van der Eecken K; De Bruycker A; Paul J; Gramme P; Ost P
World J Urol; 2019 Dec; 37(12):2557-2564. PubMed ID: 30578441
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic significance of bone marrow metastases: evaluation of 58 cases.
Kucukzeybek BB; Calli AO; Kucukzeybek Y; Bener S; Dere Y; Dirican A; Payzin KB; Ozdemirkiran F; Tarhan MO
Indian J Pathol Microbiol; 2014; 57(3):396-9. PubMed ID: 25118730
[TBL] [Abstract] [Full Text] [Related]
4. Serum immunoglobulins in genitourinary malignancies.
Schmidt JD; Feldbush TL; Weinstein SH; Bonney WW
J Urol; 1976 Mar; 115(3):293-5. PubMed ID: 943578
[TBL] [Abstract] [Full Text] [Related]
